Omentin as a novel biomarker of metabolic risk factors

<p>Abstract</p> <p>Background</p> <p>Omentin is an adipocytokine that is abundantly expressed in visceral fat tissue. We investigated the association of omentin with the number of metabolic risk factors.</p> <p>Finding</p> <p>The study population...

Full description

Bibliographic Details
Main Authors: Shibata Rei, Ouchi Noriyuki, Takahashi Ryotaro, Terakura Yuya, Ohashi Koji, Ikeda Nobuo, Higuchi Akiko, Terasaki Hiroko, Kihara Shinji, Murohara Toyoaki
Format: Article
Language:English
Published: BMC 2012-07-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Online Access:http://www.dmsjournal.com/content/4/1/37
Description
Summary:<p>Abstract</p> <p>Background</p> <p>Omentin is an adipocytokine that is abundantly expressed in visceral fat tissue. We investigated the association of omentin with the number of metabolic risk factors.</p> <p>Finding</p> <p>The study population comprised 201 Japanese men who underwent annual health checkups. Plasma omentin levels were determined by enzyme-linked immunosorbent assay. We divided the subjects into 4 groups according to omentin levels. A reduction of plasma omentin levels significantly correlated with an increase in the mean number of metabolic risk factors such as increased waist circumference, dyslipidemia, high blood pressure and glucose intolerance.</p> <p>Conclusions</p> <p>Circulating omentin levels negatively correlated with the multiplicity of metabolic risk factors, suggesting that omentin acts as a biomarker of metabolic disorders.</p>
ISSN:1758-5996